Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

For Bristol, Onglyza Disappoints And Health Care Reform Takes A Toll

May 03 2010

• By The Pink Sheet

Related Content

AstraZeneca/Bristol's Diabetes Drug Onglyza Cleared

Jul 31 2009

At Investor Meeting, Spotlight is on Bristol-Myers CEO-Designate Lamberto Andreotti --and Pipeline

Mar 04 2010

Novo Nordisk's GLP-1 Victoza Off To A Good Start

Apr 27 2010

340B Entities Will Continue Fighting For Inpatient Drug Discounts

Apr 22 2010

J&J Braces For Health Care Reform Hit, But Can "Accommodate" Impact

Apr 20 2010

Bristol Sacrifices Part Of Indication For Kidney Transplant Drug Belatacept

Mar 08 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window